PLATELET ACTIVATION MARKERS AS PREDICTORS OF DISEASE AND OF RESPONSE TO THERAPY AND FOR MONITORING THERAPEUTIC PROGRESS

摘要

Methods for assessing patient risk for platelet-affected disease states are disclosed. Also disclosed are methods for predicting the appropriateness of platelet antagonist therapy, and for monitoring patients during therapeutic intervention or during a combined regimen of therapy and angioplasty.